What are you searching for?

Sign in
Breaking News, Promotions & Moves

Athersys Appoints Mfg. SVP

Mr. Gregory Liposky, MBA joins the company with nearly four decades of industry experience

Athersys announced the addition of an experienced manufacturing executive to oversee manufacturing operations and help plan for and lead the Company’s transition into commercial manufacturing of MultiStem®. Mr. Gregory Liposky, MBA will serve as the Company’s senior vice president of Commercial Manufacturing. 

 
Athersys has been actively working with regulatory agencies, performing internal process development work, establishing working relationships with international Contract Manufacturing Organizations (CMOs) and developing other capabilities and capacity with additional hires at key positions. Mr. Liposky will work extensively with the Company’s process development, supply chain, logistics, quality and regulatory functions to position the Company to meet its continued requirements for growth.

Mr. Liposky comes to Athersys with more than 35 years of experience in leading biopharmaceutical manufacturing operations and process development efforts for domestic and international biopharmaceutical companies. He has held key leadership positions at Mallinckrodt Pharmaceuticals, MedImmune LLC, Questcor Pharmaceuticals, Verax Corporation, Creative Biomolecules Inc., and GTC Biotherapeutics Inc. 

“Athersys is committed to continuing to establish manufacturing capabilities that will support our goal of successful development and commercialization of best in class cell therapy treatments, as evidenced by the partnership we have with Nikon Cell Innovation in Japan, our longstanding relationship with Lonza, and our affiliation with other CMOs that we are actively working with,” said Dr. John Harrington, executive vice president and chief scientific officer at Athersys. “We are excited to have Greg join our team and look forward to advancing and expanding our manufacturing capabilities with his experience and guidance,” 

“It’s a pleasure to have the opportunity to join the Athersys team and to help lead and shape the vision regarding manufacturing operations and other core capabilities that are critical to positioning the company for commercial success,” commented Mr. Greg Liposky, MBA, senior vice president of Commercial Manufacturing at Athersys. “Athersys is already recognized as an established leader in the rapidly growing regenerative medicine and cell therapy sector, and has created an exciting portfolio of programs that have the potential to advance or even transform medical care in some very important areas.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics